文献速递冠心病

腔内影像指导支架置入对ACS患者2年预后的影响

[The impact of intravascular imaging-guided coronary stent implantation on clinical outcomes in patients with acute coronary syndrome].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2026-01-01

结果显示腔内影像指导组2年MACE累积发生率显著低于造影指导组,主要归因于心原性死亡和非致死性心肌梗死减少。结论为腔内影像指导支架置入可显著降低ACS患者2年MACE风险,独立于病变复杂程度。

要点

  • ACS患者支架置入应优先考虑腔内影像指导,可降低2年MACE风险。
  • 腔内影像指导的获益主要来自减少心原性死亡和非致死性心肌梗死。
  • 无论是否存在复杂病变,腔内影像指导均与更低的MACE累积发生率相关。

核心结论

  • 与冠状动脉造影指导相比,腔内影像指导支架置入能显著降低ACS患者2年MACE风险,独立于病变复杂程度。

研究设计与样本

  • 主要终点为术后2年MACE,包括心原性死亡、非致死性心肌梗死和缺血驱动的血运重建,使用Kaplan-Meier法、log-rank检验及Cox回归分析。

主要发现

  • 与造影指导组相比,腔内影像指导组支架总数较少、支架及后扩张球囊最大直径较大、后扩张比例较高(P均<0.05)。
  • 匹配前腔内影像指导组2年MACE累积发生率低于造影指导组(7.3%比13.0%,Plog-rank<0.001)。
  • 匹配前腔内影像指导组心原性死亡率为2.1%比7.5%(Plog-rank<0.001),非致死性心肌梗死率为0.9%比2.4%(Plog-rank=0.002)。
  • 倾向性评分匹配后,腔内影像指导组MACE、心原性死亡及非致死性心肌梗死发生率仍低于造影指导组(Plog-rank均<0.05)。

关键数值与推荐

  • 腔内影像指导是2年MACE的独立保护因素:HR=0.61,95%CI 0.44~0.85。
  • 腔内影像指导是非致死性心肌梗死的独立保护因素:HR=0.45,95%CI 0.21~0.96。
  • 腔内影像指导是心原性死亡的独立保护因素:HR=0.44,95%CI 0.27~0.71。

临床怎么用

  • 对于ACS患者行支架置入时,可优先考虑使用腔内影像指导以优化支架置入并改善2年预后。
  • 无论病变是否复杂,腔内影像指导均可带来MACE降低的获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the impact of intravascular imaging-guided versus angiography-guided stent implantation on clinical outcomes in patients with acute coronary syndrome (ACS). Methods: This study was a retrospective cohort study. Between January 2023 and October 2023, 3 220 ACS patients who underwent coronary stent implantation at the Second Affiliated Hospital of Harbin Medical University were consecutively enrolled. Patients were divided into intravascular imaging-guided group (n=2 550) and angiography-guided group (n=670) based on whether intravascular imaging was used during the procedure. Patients from both groups were matched through 1∶1 propensity score matching according to clinical and angiographic characteristics, yielding 625 patients in each group. The primary endpoint was 2-year major adverse cardiovascular events (MACE), including cardiac death, non-fatal myocardial infarction, and ischemia-driven revascularization. Cumulative event rates were estimated using the Kaplan-Meier method and compared with the log-rank test; subgroup analysis was performed based on the presence or absence of complex lesions. Cox proportional hazards regression models were used to evaluate the impact of intravascular imaging guidance on patient prognosis. Results: The age of patients was (62.4±10.5) years, and 2 203 (68.4%) were male. Compared with the angiography-guided group, the intravascular imaging-guided group had fewer stents implanted, larger maximum diameters of both stents and post-dilation balloons, and a higher proportion of post-dilation (all P<0.05). The intravascular imaging-guided group had a significantly lower cumulative incidence of 2-year MACE than the angiography-guided group (7.3% vs. 13.0%, Plog-rank<0.001); which was primarily attributed to a lower incidence of cardiac death (2.1% vs. 7.5%, Plog-rank<0.001) and non-fatal myocardial infarction (0.9% vs. 2.4%, Plog-rank=0.002). After propensity score matching, the intravascular imaging-guided group still had a lower risk of MACE, cardiac death, and non-fatal myocardial infarction compared with the angiography-guided group (all Plog-rank<0.05). Multivariable Cox regression analysis showed that intravascular imaging guidance was an independent protective factor for 2-year MACE (HR=0.61, 95%CI 0.44-0.85), non-fatal myocardial infarction (HR=0.45, 95%CI 0.21-0.96), and cardiac death (HR=0.44, 95%CI 0.27-0.71). Subgroup analysis further demonstrated that, regardless of lesion complexity, the cumulative incidence of MACE was lower in the intravascular imaging-guided group compared with the angiography-guided group (all Plog-rank<0.05), with no interaction effect observed (Pinteraction=0.928). Conclusion: Compared with angiography guidance, intravascular imaging-guided stent implantation significantly reduces the risk of 2-year MACE in ACS patients, regardless of the presence of complex lesions. 目的: 评估与冠状动脉造影指导相比,腔内影像指导支架置入对急性冠脉综合征(ACS)患者临床结局的影响。 方法: 本研究为回顾性队列研究,连续纳入2023年1至10月于哈尔滨医科大学附属第二医院接受冠状动脉支架置入治疗的ACS患者3 220例。根据术中是否使用腔内影像学检查,分为腔内影像指导组(2 550例)和冠状动脉造影指导组(670例)。根据临床特征、造影资料以1∶1的比例对两组患者进行倾向性评分匹配,最终两组各纳入625例患者。主要终点为术后2年主要不良心血管事件(MACE),包括心原性死亡、非致死性心肌梗死和缺血驱动的血运重建。使用Kaplan-Meier法计算累积事件率,采用log-rank检验进行比较,并根据是否存在复杂病变进行亚组分析。使用Cox比例风险回归模型评估腔内影像学指导对患者预后的影响。 结果: 患者年龄为(62.4±10.5)岁,其中男性2 203例(68.4%)。与冠状动脉造影指导组相比,腔内影像指导组的支架总数较少、支架及后扩张球囊的最大直径均较大,后扩张的比例较高(P均<0.05)。腔内影像指导组的2年MACE累积发生率明显低于冠状动脉造影指导组(7.3%比13.0%,Plog-rank<0.001),主要归因于腔内影像指导组有更低的心原性死亡率(2.1%比7.5%,Plog-rank<0.001)和非致死性心肌梗死率(0.9%比2.4%,Plog-rank=0.002)。倾向性评分匹配后,与冠状动脉造影指导组相比,腔内影像指导组的MACE、心原性死亡及非致死性心肌梗死的发生率仍更低(Plog-rank均<0.05)。多因素Cox回归分析结果显示,腔内影像指导是2年MACE(HR=0.61,95%CI 0.44~0.85)、非致死性心肌梗死(HR=0.45,95%CI 0.21~0.96)和心原性死亡(HR=0.44,95%CI 0.27~0.71)的独立保护因素。亚组分析进一步表明,无论是否为复杂病变,相比于冠状动脉造影指导组,腔内影像指导组的MACE累积发生率均更低(Plog-rank均<0.05),不存在交互作用(P交互=0.928)。 结论: 与冠状动脉造影指导相比,腔内影像指导的支架置入能显著降低ACS患者2年MACE风险,独立于病变复杂程度。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Cui, Dai, Fang, et al. [The impact of intravascular imaging-guided coronary stent implantation on clinical outcomes in patients with acute coronary syndrome]. Zhonghua Xin Xue Guan Bing Za Zhi. 2026. PMID: 42161622. doi:10.3760/cma.j.cn112148-20260114-00031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。